Publications by authors named "Barbara Romanowski"

Claim this Profile
T
The return of syphilis in Canada: A failed plan to eliminate this infection.
Ameeta E Singh, Barbara Romanowski

J Assoc Med Microbiol Infect Dis Can· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective review of tertiary and neurosyphilis cases in Alberta, 1973-2017.
Takaaki Landry, Petra Smyczek, Ryan Cooper, Jennifer Gratrix, Lindsay Bertholet, Barbara Romanowski

BMJ Open· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study.
Barbara Romanowski, Tino F Schwarz, Linda Ferguson, Klaus Peters, Marc Dionne

Hum Vaccin Immunother· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine for the prevention of cervical cancer and HPV-related diseases.
S Rachel Skinner, Dan Apter, Newton De Carvalho, Diane M Harper, Ryo Konno, Barbara Romanowski

Expert Rev Vaccines· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
Cosette M Wheeler, S Rachel Skinner, M Rowena Del Rosario-Raymundo, Suzanne M Garland, Archana Chatterjee, Barbara Romanowski

Lancet Infect Dis· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial.
Agnihotram V Ramanakumar, Paulo Naud, Cecilia M Roteli-Martins, Newton S de Carvalho, Paola C de Borba, Barbara Romanowski

BMJ Open· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progression of HPV infection to detectable cervical lesions or clearance in adult women: Analysis of the control arm of the VIVIANE study.
S Rachel Skinner, Cosette M Wheeler, Barbara Romanowski, Xavier Castellsagué, Eduardo Lazcano-Ponce

Int J Cancer· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of gonococcal infection among adults and youth: New key recommendations.
Lisa Pogany, Barbara Romanowski, Joan Robinson, Margaret Gale-Rowe, Cathy Latham-Carmanico

Can Fam Physician· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.
Aimée R Kreimer, Frank Struyf, Maria Rowena Del Rosario-Raymundo, Allan Hildesheim, S Rachel Skinner, Barbara Romanowski

Lancet Oncol· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination: results from a randomized study.
Barbara Romanowski, Tino F Schwarz, Linda M Ferguson, Murdo Ferguson, Klaus Peters

Hum Vaccin Immunother· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Dan Apter, Cosette M Wheeler, Jorma Paavonen, Xavier Castellsagué, Suzanne M Garland, Barbara Romanowski

Clin Vaccine Immunol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 4-year interim follow-up of the phase 3, double-blind, randomised controlled VIVIANE study.
S Rachel Skinner, Anne Szarewski, Barbara Romanowski, Suzanne M Garland, Eduardo Lazcano-Ponce

Lancet· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial.
Xavier Castellsagué, Jorma Paavonen, Unnop Jaisamrarn, Cosette M Wheeler, S Rachel Skinner, Barbara Romanowski

BMC Infect Dis· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: analysis of the control arm of PATRICIA.
Xavier Castellsagué, Paulo Naud, Song-Nan Chow, Cosette M Wheeler, Maria Julieta V Germar, Barbara Romanowski

J Infect Dis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural history of progression of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study.
Unnop Jaisamrarn, Xavier Castellsagué, Suzanne M Garland, Paulo Naud, Johanna Palmroth, Barbara Romanowski

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta.
Carmen Pittman, Sabrina Plitt, Ted Birse, Karen Doucette, Barbara Romanowski

Can J Infect Dis Med Microbiol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anal intraepithelial neoplasia: review and recommendations for screening and management.
Petra Smyczek, Ameeta E Singh, Barbara Romanowski

Int J STD AIDS· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against low-risk HPV types (PATRICIA randomized trial): an unexpected observation.
Anne Szarewski, S Rachel Skinner, Suzanne M Garland, Barbara Romanowski, Tino F Schwarz

J Infect Dis· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
Ameeta E Singh, Jennifer Gratrix, Ron Read, Marguerite Lovgren, Steven J Drews, Barbara Romanowski

Sex Transm Dis· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial.
Edith Roset Bahmanyar, Jorma Paavonen, Paulo Naud, Jorge Salmerón, Song-Nan Chow, Barbara Romanowski

Gynecol Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Cosette M Wheeler, Xavier Castellsagué, Suzanne M Garland, Anne Szarewski, Jorma Paavonen, Barbara Romanowski

Lancet Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
Matti Lehtinen, Jorma Paavonen, Cosette M Wheeler, Unnop Jaisamrarn, Suzanne M Garland, Barbara Romanowski

Lancet Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared with the licensed 3-dose schedule: results from a randomized study.
Barbara Romanowski, Tino F Schwarz, Linda M Ferguson, Klaus Peters, Marc Dionne

Hum Vaccin· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®).
Kate McKeage, Barbara Romanowski

BioDrugs· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.
Kate McKeage, Barbara Romanowski

Drugs· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis